SciencemRNA Cancer Vaccine Halts Melanoma in Phase 3 TrialModerna and Merck's personalized mRNA vaccine stopped melanoma returning post-surgery in a landmark Phase 3 trial of 1,000 high-risk patients.
ScienceFridge-Free Vaccine Passes First Human TrialUK biotech Stablepharma's powder tetanus vaccine needs no refrigeration — and a world-first trial with 60 volunteers showed encouraging results.
NewsOxford's Malaria Vaccine Wins Top European Inventor PrizeSir Adrian Hill's R21/Matrix-M malaria vaccine — up to 80% effective and under €3 per dose — earned him the 2026 European Inventor Award.
